Company news
Co-diagnostics, Inc. (NASDAQ:CODX) news
Every Co-diagnostics, Inc. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Co-Diagnostics Participates in Medical Devices and Innovations Roundtable Media Event
August 18, 2026
Co Diagnostics : Reports Second Quarter 2026 Financial Results
August 13, 2026
Co-Diagnostics Reports Second Quarter 2026 Financial Results
August 13, 2026
Co-Diagnostics Announces Second Quarter 2026 Earnings Release Date and Webcast
July 30, 2026
Co-Diagnostics Joint Venture CoSara Provides Ebola Test Kits for Analytical Studies
July 28, 2026
Co-Diagnostics Joint Venture CoSara Initiates Clinical Studies in India for Tuberculosis Test on PCR Platform
July 22, 2026
Co Diagnostics : Appoints Wes Lindsey, PhD, MBA as Chief Scientific Officer
July 16, 2026
Co-Diagnostics Invited to Participate in NPOC Tuberculosis Diagnostics Workshop in Bangkok, Thailand
July 8, 2026
Co-Diagnostics Vector Smart® Division Expands Footprint to 21 States
June 25, 2026
Co-Diagnostics Hosts Kingdom of Saudi Arabia Joint Venture CoMira for Unveiling of Future Automated Manufacturing Line
June 18, 2026
Co-Diagnostics Advances Latin American Commercialization Strategy for Co-Dx™ PCR Pro® with Mexico Distributor Agreement
June 11, 2026
Co-Diagnostics and CoSara Advance Ebola PCR Test Development and Co-Dx™ PCR Point-of-Care Platform Capabilities
June 2, 2026
Co-Diagnostics Advances Ebola PCR Assay Development Strategy with Joint Venture CoSara
May 26, 2026
Co-Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak Alert
May 19, 2026
Co-Diagnostics Reports First Quarter 2026 Financial Results
May 14, 2026
Co-Diagnostics Joint Venture CoMira Finalizes Lease Agreement for Manufacturing Facility in Saudi Arabia's Sudair Industrial City
May 8, 2026
Co-Diagnostics Announces First Quarter 2026 Earnings Release Date and Webcast
April 30, 2026
Co-Diagnostics Invited to Present at Stop TB Partnership Summit in Washington, D.C.
April 16, 2026
Co-Diagnostics to Showcase Co-Dx PCR Platform and CE-IVD Solutions at ESCMID 2026 in Munich, Germany
April 14, 2026
Co-Diagnostics Executives to Participate in European Trade Mission with Utah Governor and WTC Utah
April 9, 2026
Co-Diagnostics Joint Venture CoMira Receives Approval for Manufacturing Facility in Kingdom of Saudi Arabia's Sudair Industrial City
April 2, 2026
Co-Diagnostics Reports Full Year 2025 Financial Results
March 31, 2026
Co-Diagnostics Ships Diagnostic Materials to India for Initiation of Tuberculosis Clinical Studies Following Recently Issued Guidance fro...
March 25, 2026
Co-Diagnostics Signs Agreement to Significantly Expand Commercial and Distribution Territory Across South Asia
March 20, 2026
Co-Diagnostics Announces Fourth Quarter and Full Year 2025 Earnings Release Date and Webcast
March 17, 2026
Co-Diagnostics to Present at Medical Korea 2026
March 16, 2026
Co-Diagnostics Receives Japanese Patent Covering Co-Dx PCR Platform Technologies
March 12, 2026
Co-Diagnostics Regains Compliance with Nasdaq Listing Requirements
March 10, 2026
Co-Diagnostics to Showcase PCR Platform at World Health Expo Labs Dubai
February 9, 2026
Co-Diagnostics Joint Venture CoSara Receives CDSCO License to Manufacture and Sell CoSara PCR Pro™ Instrument
February 5, 2026
Co-Diagnostics JV, CoSara, Receives ISO 13485 Certification in Preparation for Manufacturing Upcoming PCR Platform
February 4, 2026
Co-Diagnostics JV CoSara Participates in Regional Conferences to Grow and Strengthen Distributor Relationships
January 12, 2026
Co-Diagnostics Announces Reverse Stock Split
December 30, 2025
Co-Diagnostics Receives Grant of Australian Patent Covering Co-Dx PCR Platform Technologies
December 29, 2025
Co-Diagnostics Joint Venture, CoSara, Invited to Participate in 2nd Advanced TB Diagnostics Course in Chennai, India
December 18, 2025
Co-Diagnostics Performs Analysis of Influenza Co-Primers® to Confirm Reactivity Against Flu A H3N2 Mutation
December 17, 2025
Co-Diagnostics to Present on Co-Dx™ PCR Platform and AI Integration at Point-of-Care Testing 2025
December 9, 2025
Co-Diagnostics JV, CoSara, to Participate at VIROCON 2025 in Pune, India
December 8, 2025
Co-Diagnostics Delivers Address about Tuberculosis Test Adoption and Implementation at The Union World Conference on Lung Health
November 20, 2025
Co-Diagnostics Initiates Clinical Evaluations for Upper Respiratory Multiplex Point-of-Care Test on Co-Dx™ PCR Platform to Support Submis...
November 18, 2025
Co-Diagnostics Reports Third Quarter 2025 Financial Results
November 13, 2025
Utah Governor Cox and BioUtah Recognize Co-Diagnostics Following Recent JV Announcement in Kingdom of Saudi Arabia
November 12, 2025
Co-Diagnostics Engages Maxim Group to Pursue SPAC Transaction for its Indian Joint Venture, CoSara Diagnostics Pvt. Ltd
November 5, 2025
Co-Diagnostics to Integrate and Implement Proprietary Artificial Intelligence Technology into Co-Dx™ Primer Ai™ Platform
November 3, 2025
Co-Diagnostics, Inc. Announces Third Quarter 2025 Earnings Release Date and Webcast
October 31, 2025
Co-Diagnostics to Host Fireside Chat on November 5th with CEO, Dwight Egan, to Discuss Recently Announced Definitive Agreement in Saudi A...
October 30, 2025
Co-Diagnostics, Inc. Announces Closing of $7.0 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
October 29, 2025
Co-Diagnostics, Inc. Announces Pricing of $7.0 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
October 28, 2025
Co-Diagnostics Signs Definitive Agreement with Arabian Eagle in the Kingdom of Saudi Arabia to Establish CoMira Diagnostics and Localize ...
October 27, 2025
Co-Diagnostics Executive Leadership Team to Attend Global Health Exhibition 2025 in Riyadh, Saudi Arabia
October 22, 2025